Galiximab

(Synonyms: IDEC 114; Anti-Human CD80 Recombinant Antibody)
1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Galiximab (IDEC-114) is a primatized monoclonal IgG1 antibody targeting CD80. Galiximab variable regions are primatized, and the constant regions are humanized. Galiximab induces antibody-dependent cellular cytotoxicity by blocking CD80-CD28 binding. Galiximab has antitumor activity and can induce apoptosis in tumor cells. Galiximab can be used in the research of relapsed Hodgkin lymphoma and solid tumors.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.23%
  • CAS. Nr.: 357613-77-5
  • Molecular Weight:145.24 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Galiximab

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00